AIG, which wants to spin off its Taiwan-based Nan Shan Life Insurance unit, has a few live ones nibbling on the line to snap it up, according to a Bloomberg report. The company has disclosed in an SEC filing that Nan Shan has a…
Last week, power-plant operator Dynegy agreed to be acquired by top shareholder Icahn Enterprises for about $665 million. But Dynegy’s second-largest shareholder, hedge fund Seneca Capital, rejected the bid, calling it “the wro…
The U.S. biotech is holding an analyst and investor meeting focused on the commercial potential of its multiple sclerosis drug Campath. The goal: to convince Paris-based Sanofi-Aventis to raise its hostile takeover offer in a b…